Abstract
Overactive bladder (OAB) is frequently treated with antimuscarinic agents; however, the serotonin-noradrenaline reuptake inhibitor (SNRI) duloxetine has demonstrated efficacy in animal models of OAB, and might be effective in humans.
Original language | English |
---|---|
Pages (from-to) | 188-189 |
Journal | Nature Reviews Urology |
Volume | 5 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2008 |